Navigation Links
Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products

BETHESDA, Md., Aug. 10 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced that it has entered into two new exclusive, multi-year distribution agreements for China with Biotest AG and Cutera Inc.

Biotest AG, based in Dreieich, Germany (SDAX: BIO3), specializes in innovative hematology and immunology products. Biotest has appointed Chindex as the exclusive distributor for its unique Tango Optimo Automated Blood Bank System for the People's Republic of China. The Tango Optimo automates all routine testing procedures performed in blood banking, including blood grouping, antibody screening, and cross matching, and is the only blood bank analyzer that offers seven-day on-board storage of liquid and microplate reagents. Upon receipt of regulatory approval from China's State Food and Drug Administration, Chindex will market the Tango Optimo to hospital laboratories along with the Johnson & Johnson Ortho Clinical Diagnostics line of clinical chemistry analyzers.

Cutera Inc. (Nasdaq: CUTR) is a leading manufacturer of upgradeable, easy-to-use laser and other light-based aesthetic systems used by physicians and other qualified practitioners worldwide. Under the terms of the agreement, Chindex will market and distribute the upgradeable Xeo, Solera, and CoolGlide platforms in China and Hong Kong. The Cutera family of lasers, several of which have already been registered with the Chinese State Food and Drug Administration, provides an excellent complement to present Chindex product line.

Roberta Lipson, Chindex President and CEO, commented from Beijing, "We are excited to be announcing these partnerships with industry-leading manufacturers that will widen the breadth of products that Chindex can now offer to China's healthcare communities. Importantly, both of these exclusive agreements leverage our existing leadership in their respective target markets in China. Over our 28-year history, Chindex has installed top quality medical equipment in over 3,000 hospitals throughout China and Hong Kong, many of which are repeat customers."

Today's announcement follows the Company's recently announced distribution agreement with Vital Images, Inc (Nasdaq: VTAL), a leading provider of advanced visualization and analysis software solutions employed by radiologists, cardiologists, oncologists, and other medical specialists to create 2D, 3D and 4D images of human anatomy from CT and MR image data. Vital Images' Vitrea(R) software is already approved by the State Food and Drug Administration for sale in China, and Chindex is currently marketing the product to hospitals throughout China along with the innovative imaging products from Siemens and Hologic.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. Healthcare services are provided through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing, Shanghai, Guangzhou and Wuxi. The Company sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, for which the Company is the exclusive distribution partner for the sale and servicing of color ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-seven years of experience, approximately 1,300 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites and .

Safe Harbor Statement

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in our annual report on Form 10-K for the year ended March 31, 2009, updates and additions to those "Risk Factors" in our interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We have no obligation to update these forward-looking statements.

    For further information, please contact:

    Integrated Corporate Relations
     Ashley M. Ammon
     Tel: +1-203-682-8200

SOURCE Chindex International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, Inc. Launches World-Class Cancer Treatment Center
2. Chindex International, Inc. to Report First Quarter Fiscal 2010 Financial Results
3. Chindex International and Vital Images Sign Reseller Agreement
4. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
5. Chindex International, Inc. Announces May Conference Participation
6. Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009
7. Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results
8. Chindex International, Inc. to Participate in UBS Global Healthcare Services Conference
9. Chindex International, Inc. to Report Fiscal Third Quarter 2009 Financial Results
10. Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference
11. Chindex International, Inc. Adopts Voluntary Executive Compensation Restrictions
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a ... for a child’s exposure limits. , The original Nov 2015 CR story titled, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Medicalis, a ... Radiology Society of North America (RSNA) annual meeting, being held November 29 – ... 2014. Throughout 2015, the company has completed installations for Integrated Delivery Network ...
(Date:11/30/2015)... , ... November 30, 2015 , ... It’s inevitable that ... family member, close friend, or animal pass away, death lives among us. It is ... , Coming from a family of 11 children, author T Sky understands that she ...
(Date:11/30/2015)... ... ... The successful filing of an Investigational New Drug application (IND) is a ... key industry segment, Regis Technologies has decided to sponsor and participate in an XTalks-hosted ... , Federal law does not allow new drugs to cross state lines until it ...
(Date:11/30/2015)... ... 2015 , ... Scott Newman MD, FACS of New York’s ... surgeons in the New York City area to utilize the new, non-invasive SculpSure™ ... laser treatment for fat loss in the abdomen, flanks, and other areas that ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015   Nuance Communications, Inc. (NASDAQ: ... Support Company (NDSC) today jointly announced a new ... that utilize the American College of Radiology,s (ACR) Imaging ... to comply with current and emerging value-based payment ... --> By combining clinical decision support, radiology reporting ...
(Date:11/30/2015)... 30, 2015  Hanger, Inc. (NYSE: HGR ) ... the terms of its previously announced consent solicitation (as ... $200,000,000 aggregate principal amount 7⅛% Senior Notes due 2018 ... consent fees payable pursuant to the Consent Solicitation, (ii) ... (iii) the expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: